文献速递脑血管病外科

PHASES与ELAPSS评分与动脉瘤生长相关:一项431例未破裂颅内动脉瘤研究

PHASES and ELAPSS Scores Are Associated with Aneurysm Growth: A Study of 431 Unruptured Intracranial Aneurysms.
PubMed 文献 · World Neurosurg · 2018-03-10

该回顾性研究分析了在本机构随访至少6个月的431例未破裂颅内动脉瘤,中位随访4.8年,40个动脉瘤(9.3%)生长,年化生长率2.0%/年。当前吸烟、动脉瘤大小、PHASES评分和ELAPSS评分与动脉瘤生长相关。

要点

  • 当前吸烟是唯一可改变的生长相关危险因素,吸烟者年生长率5.1%,从不吸烟者1.5%。
  • 动脉瘤大小(OR 1.22)、ELAPSS评分(OR 1.10)和PHASES评分(OR 1.24)与动脉瘤生长相关。
  • 年龄、部位、既往蛛网膜下腔出血和高血压与动脉瘤生长无独立关联。

核心结论

  • 该回顾性研究提示动脉瘤大小、吸烟状态、PHASES评分和ELAPSS评分与动脉瘤生长相关。

研究设计与样本

  • 回顾性研究,连续纳入本机构15年间随访至少6个月的未破裂颅内动脉瘤,共352例患者431个动脉瘤。

主要发现

  • 随访期间40个动脉瘤(9.3%)生长,年化生长率为2.0%/年,平均随访4.8年,共2100个动脉瘤年。
  • 当前吸烟者动脉瘤年生长率5.1%,从不吸烟者1.5%(P=0.0004)。
  • 动脉瘤大小与生长相关(OR 1.22,95%CI 1.11-1.33,P<0.0001)。
  • ELAPSS评分与生长相关(OR 1.10,95%CI 1.09-1.11,P<0.0001)。
  • PHASES评分与生长相关(OR 1.24,95%CI 1.20-1.28,P<0.0001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding risk factors for intracranial aneurysm growth is important for patient management. We performed a retrospective study examining risk factors for the growth of unruptured intracranial aneurysms followed at our institution, evaluating both traditional risk factors and the PHASES (Population, Hypertension, Age, Size, Earlier Subarachnoid Hemorrhage, Site) score. METHODS: We retrospectively reviewed a consecutive series of unruptured intracranial aneurysms followed at our institution for a minimum of 6 months over a 15-year period. The primary outcome of this study was aneurysm growth, defined as a ≥1-mm increase in maximum diameter. Risk factors studied included PHASES score, ELAPSS (Earlier Subarachnoid Hemorrhage, Location of Aneurysm, Age, Population, Size, and Shape) score, demographics, multiple aneurysms, previous subarachnoid hemorrhage, family history of aneurysm or subarachnoid hemorrhage, smoking, hypertension, and aneurysm shape, size, and location. The χ2 test was used for comparison of categorical variables, and the Student t test was used for continuous variables. RESULTS: The study cohort comprised 352 patients with a total of 431 unruptured intracranial aneurysms. The mean duration of follow-up was 4.8 years, and there was a total of 2100 aneurysm-years of follow-up. Forty aneurysms (9.3%) grew, for an annualized growth rate of 2.0% of aneurysms/year. Current smoking status was the sole modifiable risk factor associated with growth (growth rate of 5.1%/year compared with 1.5%/year for never smokers; P = 0.0004). Increasing size (odds ratio [OR], 1.22; 95% confidence interval [CI], 1.11-1.33; P < 0.0001), ELAPSS score (OR, 1.10; 95% CI, 1.09-1.11; P < 0.0001), and PHASES score (OR, 1.24; 95% CI, 1.20-1.28; P < 0.0001) were associated with growth as well. Age, location, previous subarachnoid hemorrhage, and hypertension were not independently associated with aneurysm growth. CONCLUSIONS: Our retrospective study suggests that aneurysm size, smoking status, PHASES score, and ELAPSS score are associated with aneurysm growth.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Brinjikji W, Pereira VM, Khumtong R, et al. PHASES and ELAPSS Scores Are Associated with Aneurysm Growth: A Study of 431 Unruptured Intracranial Aneurysms. World Neurosurg. 2018. PMID: 29530704. doi:10.1016/j.wneu.2018.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。